Ana Stegic Email

Executive Director Clinical Operations . Antibe Therapeutics

Current Roles

Employees:
23
Revenue:
$3.6M
About
Antibe Therapeutics is a publicly traded biotechnology company pursuing a breakthrough advance in the treatment of inflammation. Our drug pipeline addresses major markets in non-addictive management of chronic and post-surgical pain. Antibe's lead drug, now in late Phase 2 trials, is demonstrating unprecedented safety in the treatment of chronic pain, a condition that affects more than 50 million Americans alone. Our second pipeline drug is intended to replace a range of opioids, addressing a vast and pressing public health concern. Our third drug is a safer daily aspirin -- delivering anti-stroke and anti-cancer benefits without damage to the digestive tract.
Antibe Therapeutics Address
15 Prince Arthur Avenue
Toronto, ON
CAN

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.